GRANISETRON HYDROCHLORIDE injection Bandaríkin - enska - NLM (National Library of Medicine)

granisetron hydrochloride injection

wockhardt limited - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. it is not known whether granisetron is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when granisetron hydrochloride injection is administered to a nursing woman. chemotherapy-induced nausea and vomiting [see dosage and administration (2)]  for use in chemotherapy-induced nausea and vomiting in pediatric patients 2 to 16 years of age. safety and effectiveness in pediatric patients under 2 years of age have not been established.

GRANISETRON HYDROCHLORIDE INJECTION Liquide Kanada - franska - Health Canada

granisetron hydrochloride injection liquide

omega laboratories limited - granisétron (chlorhydrate de granisétron) - liquide - 1mg - granisétron (chlorhydrate de granisétron) 1mg - 5-ht3 receptor antagonists

GRANISETRON HYDROCHLORIDE tablet, film coated Bandaríkin - enska - NLM (National Library of Medicine)

granisetron hydrochloride tablet, film coated

natco pharma limited - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride tablets usp are indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Granisetron Kabi Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

granisetron kabi

fresenius kabi new zealand limited - granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml - concentrate for injection - 1 mg/ml - active: granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - adults: granisetron is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy. the prevention of nausea and vomiting induced by radiotherapy. the prevention and treatment of postoperative nausea and vomiting. children: granisetron is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

KYTRIL granisetron (as hydrochloride) 1mg/1mL injection Ástralía - enska - Department of Health (Therapeutic Goods Administration)

kytril granisetron (as hydrochloride) 1mg/1ml injection

atnahs pharma australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium hydroxide; sodium chloride; hydrochloric acid - adults:,kytril (tablets and injection) is indicated for use in adults for:,the prevention of nausea and vomiting induced by cytotoxic chemotherapy; the prevention of nausea and vomiting induced by radiotherapy. kytril (injection) is also indicated for use in the treatment of nausea and vomiting induced by cytotoxic chemotherapy; and prevention and treatment of post-operative nausea and vomiting.,paediatric:,kytril injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Granisetron Fresenius Kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp. Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

granisetron fresenius kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp.

fresenius kabi sa-nv - granisetron hydrochloride 1,12 mg/ml - eq. granisetron 1 mg/ml - concentrate for solution for injection/infusion - 1 mg/ml - granisetron hydrochloride 1.12 mg/ml - granisetron

Granisetron Fresenius Kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp. Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

granisetron fresenius kabi 1 mg/ml inj./inf. sol. (conc.) i.v. amp.

fresenius kabi sa-nv - granisetron hydrochloride 1,12 mg/ml - eq. granisetron 1 mg/ml - concentrate for solution for injection/infusion - 1 mg/ml - granisetron hydrochloride 1.12 mg/ml - granisetron

GRANISETRON HYDROCHLORIDE tablet film coated Bandaríkin - enska - NLM (National Library of Medicine)

granisetron hydrochloride tablet film coated

avera mckennan hospital - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg